Open original FDA record ↗Recall record
- FDA identifier
- Z-0593-2019
- Company in FDA record
- St. Jude Medical, Inc.
- FDA record creation date
- Dec 10, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The most proximal unsegmented electrode of the Deep Brain Stimulation leads, may be constructed with MP35N instead of the required 90/10 platinum-iridium.
Source facts
- Action
- On October 11, 2018, the firm sent an Urgent Medical Device Recall Notice to customers (i.e, Hospital Administrators) via overnight mail service informing them that the firm's records indicate that the institution has/had received the affected 8-Channel Lead that may be impacted by an isolated manufacturing issue. The notification explains that the firm believes that some of the listed leads may contain an electrode that does not conform to material specification. In total, there have been four (4) reports from (2) centers describing that the most proximal stimulation tip electrode (electrode position 4) appeared lighter than the more distal electrodes when radiographed. There have been no reports of patient harm to date. Further communication with additional details about this action, inclusive of management recommendations for any patients that may have been implanted with an affected lead, will be forthcoming as soon as possible. The notification also informs the customer that the firm's representative will assist with removing these leads from the customer's account and will facilitate replacing them. The firm is requesting the customer's support on the removal and return of these leads. The FDA has been notified of this activity. In the meantime, if hospitals or it's physicians have any questions, they can contact their local Sales Representative or Abbott Support at 1-800-727-7846 (Opt3). Customers were also provided with an Acknowledgement Form and instructed to complete all requested information and to return immediately. The Acknowledgement Form included a list of the models and serial numbers of the devices that have been delivered to the facilities, but that records do not yet reflect an implant. The customer is instructed to review and indicate if the device(s) were removed or implanted. Customer are instructed to please return the Acknowledgement Form to Abbott at email: DBSNotices@Abbott.com. On October 29, 2018, the firm sending out
- Initiated
- 2018-10-11
- Root cause
- Mixed-up of materials/components
- Terminated
- 2022-09-13
- Distribution
- Worldwide distribution - US nationwide distribution in the states of AZ, CA, CO, FL, GA, IL, MD, MN, MO, MT, NC, NJ, NY, OH, PA, and WA. International distribution in the countries of Argentina, Australia, Austria, Belgium, Brazil, Colombia, Czech Republic, Finland, France, Germany, Hungary, Italy, Mexico, Poland, Russian Federation, Saudi Arabia, South Korea, Spain, Sweden, Taiwan, Turkey, and United Kingdom
- Recall number
- Z-0593-2019
- Recall status
- Terminated
- CDRH record ID
- 168771
- FDA record created
- 2018-12-10
- Recall event number
- 81461